Madrid, Spain—Biosearch Life has received organic certification for its L. fermentum CECT5716 LC40 strain, according to a press release.
The press release notes that the market for organic products has grown in recent years, thanks to increased consumer understanding of health and the environment. The market is forecast to grow by 16.44% CAGR over the 2020-2025 forecast period.
LC40 is a patented probiotic strain isolated from human breast milk, which has been shown in clinical trials to protect infants from respiratory infections and to promote breastfeeding. The press release says that the organic certification “guarantees that the product meets all established requirements and protocols, such as the best environmental practices, a high level of biodiversity, the preservation of natural resources, the application of exacting animal welfare standards, and production in accordance with the preferences of certain consumers for products obtained from natural substances and processes.”
Related: AIDP Announces Distribution Agreement with Biosearch Life
Immune Health & Beyond: What’s Trending in Raw Materials
The Organic Center Collaborates on Two USDA-Funded Projects
Monica Olivares, director of R & D at Biosearch Life, said in the press release: “It is a very important milestone for Biosearch Life to have obtained this highly important organic product certification for our Hereditum LC40 strain, which motivates us towards a greater commitment to the quality of our products. It is very gratifying to be able to differentiate ourselves to our end consumer, consequently helping to protect mothers and their babies during breastfeeding. From Biosearch Life we will continue developing our activity focused on R&D to promote the health of our consumers.”